Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo

作者: Tara L. Aghaloo , Christopher M. Amantea , Catherine M. Cowan , Jennifer A. Richardson , Ben M. Wu

DOI: 10.1002/JOR.20437

关键词:

摘要: Oxysterols, naturally occurring cholesterol oxidation products, can induce osteoblast differentiation. Here, we investigated short-term 22(S)-hydroxycholesterol + 20(S)-hydroxycholesterol (SS) exposure on osteoblastic differentiation of marrow stromal cells. We further explored oxysterol ability to promote bone healing in vivo. Osteogenic was assessed by alkaline phosphatase (ALP) activity, osteocalcin (OCN) mRNA expression, mineralization, and Runx2 DNA binding activity. To explore the effects osteogenic oxysterols vivo, utilized critical-sized rat calvarial defect model. Poly(lactic-co-glycolic acid) (PLGA) scaffolds alone or coated with 140 ng (low dose) 1400 (high cocktail were implanted into defects. Rats sacrificed at 6 weeks examined three-dimensional (3D) microcomputed tomography (microCT). Bone volume (BV), total (TV), BV/TV ratio measured. Culture SS for 10 min significantly increased ALP activity after 4 days, while 2 h mineralization 14 days. Four-hour treatment OCN measured 8 days nuclear protein an OSE2 site The defects showed slight control group. However, adsorbed low high-dose enhanced formation. Histologic examination confirmed formation sites grafted oxysterol-adsorbed scaffolds, compared mostly fibrous tissue sites. Our results suggest that brief triggered events leading cell function vitro These identify as potential agents local systemic enhancement

参考文章(64)
Byung Ho Woo, Betsy F. Fink, Richard Page, Jay A. Schrier, Yeong Woo Jo, Ge Jiang, Michelle DeLuca, Henry C. Vasconez, Patrick P. DeLuca, Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharmaceutical Research. ,vol. 18, pp. 1747- 1753 ,(2001) , 10.1023/A:1013382832091
Catherine M. Cowan, Chia Soo, Kang Ting, Benjamin Wu, Evolving Concepts in Bone Tissue Engineering Current Topics in Developmental Biology. ,vol. 66, pp. 239- 285 ,(2005) , 10.1016/S0070-2153(05)66008-5
George J. Schroepfer, Oxysterols: modulators of cholesterol metabolism and other processes. Physiological Reviews. ,vol. 80, pp. 361- 554 ,(2000) , 10.1152/PHYSREV.2000.80.1.361
QUINTEN P. RUHE, ELIZABETH L. HEDBERG, NESTOR TORIO PADRON, PAUL H.M. SPAUWEN, JOHN A. JANSEN, ANTONIOS G. MIKOS, rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. Journal of Bone and Joint Surgery, American Volume. ,vol. 85, pp. 75- 81 ,(2003) , 10.2106/00004623-200300003-00013
J. P. A. Van Den Bergh, C. M. Ten Bruggenkate, H. H. J. Groeneveld, E. H. Burger, D. B. Tuinzing, Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. Journal of Clinical Periodontology. ,vol. 27, pp. 627- 636 ,(2000) , 10.1034/J.1600-051X.2000.027009627.X
Tang Tt, Lou, Xu Xl, Yue B, Yu Cf, Dai Kr, Ectopic bone formation of human bone morphogenetic protein-2 gene transfected goat bone marrow-derived mesenchymal stem cells in nude mice. Chinese journal of traumatology. ,vol. 8, pp. 3- 7 ,(2005)
Carles Bosch, Birte Melsen, Rochelle Gibbons, Karin Vargervik, Human recombinant transforming growth factor-beta 1 in healing of calvarial bone defects. Journal of Craniofacial Surgery. ,vol. 7, pp. 300- 310 ,(1996) , 10.1097/00001665-199607000-00011
Renny T. Franceschi, Guozhi Xiao, Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways Journal of Cellular Biochemistry. ,vol. 88, pp. 446- 454 ,(2003) , 10.1002/JCB.10369
Shelley R Winn, Yunhua Hu, Charles Sfeir, Jeffrey O Hollinger, Gene therapy approaches for modulating bone regeneration. Advanced Drug Delivery Reviews. ,vol. 42, pp. 121- 138 ,(2000) , 10.1016/S0169-409X(00)00057-0